Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from HQ Specialty Pharma with status Current. The shortage was first posted on 04/10/2020.
Shortage Details
- Status
- Current
- Company
- HQ Specialty Pharma
- Package NDC
- 44567-602-24
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24)
- Initial Posting
- 04/10/2020
- Revised Date